8-K: Healthcare Realty Appoints Daniel Gabbay as New CFO

Healthcare Realty Trust announced the appointment of Daniel Gabbay as its new Executive Vice President and Chief Financial Officer, effective January 12, 2026, replacing Austen B. Helfrich.

Summary

• Daniel Gabbay has been appointed Executive Vice President and Chief Financial Officer of Healthcare Realty Trust Incorporated, effective January 12, 2026.
• Mr. Gabbay, age 46, previously served as a Managing Director in the Real Estate Investment Banking Group of RBC Capital Markets, with primary coverage responsibility of the healthcare REIT sector, and prior to that, at Barclays.
• His initial compensation package includes a base salary of $500,000 per year, an annual cash incentive opportunity at a target of $625,000 (guaranteed at target for 2026), and equity incentive awards with a target value of $1,375,000 for 2026.
• Mr. Gabbay will also receive a one-time make-whole restricted stock award with an aggregate grant date value of $2,750,000, vesting ratably over four years, and relocation benefits valued at $300,000.
• Austen B. Helfrich will depart from his position as Executive Vice President and Chief Financial Officer, effective January 12, 2026.
• Mr. Helfrich's separation is not a result of any disagreement with management or the Company's external auditor.
• The Company expects to record a charge of approximately $5 million for the quarter ended March 31, 2026, in connection with Mr. Helfrich's separation.

Sentiment

Score: 7

Explanation: The appointment of a highly experienced CFO with a strong background in healthcare REIT investment banking is a positive strategic move. The unchanged FFO guidance provides stability. The severance charge is a one-time, expected cost associated with such transitions.

Positives

• New CFO Daniel Gabbay brings nearly 20 years of investment banking experience, with primary coverage responsibility of the healthcare REIT sector, including advisory roles on significant real estate transactions.
• Mr. Gabbay holds an MBA from Harvard Business School and degrees from The Wharton School and the University of Pennsylvania, indicating a strong academic and professional background.
• The Company's previously issued 2025 Normalized FFO guidance remains unchanged, providing stability and continuity in financial outlook.
• Management expressed confidence in Mr. Gabbay's strategic insight, analytical rigor, and capital markets expertise, anticipating a strong contribution to the senior leadership team.

Negatives

• The Company expects to record a charge of approximately $5 million for the quarter ended March 31, 2026, related to the separation of the former CFO, Austen B. Helfrich.

Risks

• Forward-looking statements in the announcement include risks, uncertainties, and contingencies that could cause actual results to differ materially and adversely. Additional information concerning the Company's business, including factors that could materially and adversely affect financial results, are described under Part I, Item 1A Risk Factors, in the Company's 2024 Annual Report on Form 10-K and in its other filings with the SEC.

Future Outlook

The Company's previously issued 2025 Normalized FFO guidance remains unchanged, having been increased as part of reported third quarter 2025 financial results.

Management Comments

• "I am incredibly excited to welcome Dan to Healthcare Realty. I have known and worked closely with Dan for over two decades, and he has a proven track record of leadership and success throughout his career. Dan brings an exceptional blend of strategic insight, analytical rigor, and capital markets expertise, not to mention deep experience in our sector. I look forward to working closely with him as part of our senior leadership team going forward." Peter Scott, President and CEO.
• "I am honored by the opportunity to serve as Healthcare Realty's CFO and excited to get started. I look forward to working with the talented team at Healthcare Realty as we continue to execute upon the strategic vision which Pete and the Board laid out last year. As the leading pure-play outpatient medical REIT, Healthcare Realty has the best-in-class platform to capitalize on favorable industry trends." Daniel Gabbay.
• "I am grateful for his partnership and strong financial leadership during a critical time for Healthcare Realty. On behalf of the Company and our Board of Directors, I sincerely thank Austen for his service and wish him well in his future endeavors." Peter Scott, President and CEO, regarding Austen Helfrich.

Industry Context

The appointment of a new CFO with deep experience in the healthcare REIT sector, particularly from investment banking roles advising on significant mergers, suggests the company is positioning itself to capitalize on "favorable industry trends" within the outpatient medical REIT space. This move could signal a focus on strategic transactions, capital markets activities, or optimizing financial structures in a competitive environment.

Comparison to Industry Standards

• Healthcare Realty positions itself as the "largest, pure-play owner, operator and developer of medical outpatient buildings in the United States," indicating a specialized and leading focus within the broader REIT market.
• The company claims to have the "best-in-class platform to capitalize on favorable industry trends," suggesting a competitive advantage in its niche.
• The new CFO's advisory experience includes significant transactions like Sonida Senior Living's $3 billion combination with CNL Healthcare Properties and Healthpeak Properties' $5 billion strategic merger with Physicians Realty Trust, demonstrating a background in large-scale real estate transactions relevant to the sector.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: The appointment of an experienced CFO could be seen positively, potentially enhancing financial strategy and capital allocation. The $5 million severance charge will impact Q1 2026 earnings. Unchanged FFO guidance provides stability.
• Employees: A change in a senior executive role can sometimes create uncertainty, but the filing suggests a smooth transition.
• Management Team: The CEO expressed excitement about working with the new CFO, indicating a potentially strong working relationship.

Next Steps

• Daniel Gabbay will assume his new role as Executive Vice President and Chief Financial Officer on January 12, 2026.
• The Company expects to record a charge of approximately $5 million for the quarter ended March 31, 2026, related to Mr. Helfrich's separation.
• Mr. Helfrich's severance compensation and accelerated vesting of equity awards are subject to his execution and non-revocation of a release agreement.

Key Dates

Recommendation

The appointment of a highly qualified CFO with deep sector expertise is a positive strategic development, suggesting a focus on capital markets and strategic growth. However, the immediate financial impact includes a $5 million severance charge. The unchanged FFO guidance provides stability, but the filing does not present new information that would fundamentally alter the company's valuation or immediate growth prospects to warrant a "buy" or "sell" recommendation based solely on this announcement. It's a management transition with a clear strategic rationale, maintaining a "hold" position until further financial results or strategic initiatives are announced.

Keywords

Healthcare Realty Trust, HR, CFO, Chief Financial Officer, Daniel Gabbay, Austen Helfrich, Executive Vice President, Real Estate Investment Trust, REIT, Healthcare REIT, Corporate Governance, Management Change, SEC Filing, 8-K